No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BRIEF-GlobeImmune reports Q1 loss per share of $0.15
BRIEF-GlobeImmune hires Cantor Fitzgerald to assist in review of strategic alternatives
BRIEF-GlobeImmune reports Q2 net loss of $1.3 mln
BRIEF-GlobeImmune engages cantor Fitzgerald as financial advisor to assist with evaluation of strategic options
BRIEF-GlobeImmune Celgene Corporation entered into Celgene amendment' agreement
BRIEF-GlobeImmune authorizes eliminating majority of positions in workforce